Lawmakers Tour Chattanooga ALS Clinic

State legislators visited the Erlanger Hospital facility to discuss increased funding for research and patient care.

Updated on Oct. 20, 2026 in Stroke

Isometric editorial illustration of clean, white clinical walls with minimalist handrails, representing a professional healthcare environment for research and patient care. — State legislators visited Chattanooga’s Erlanger Hospital this week to advocate for increased funding for regional ALS research and patient therapy programs. AI Illustration. Upload story photo >

Live Poll

Should your state government increase funding for rare disease research and specialized clinic access?

Senator Bo Watson and Representative Esther Helton-Haynes toured the ALS Clinic at Erlanger Hospital to review patient care standards. Medical staff and the ALS Association used the visit to advocate for enhanced state support for clinical research and therapy services.

Why it matters

The clinic serves as the primary regional hub for those with the progressive muscle disease, and staff are pushing for expanded local resources. Current efforts focus on establishing clinical trials and ensuring consistent access to multidisciplinary care for patients.

Approximately 600 Tennesseans currently live with ALS, a disease characterized by progressive muscle weakness. This visit follows the 2026 legislative approval of $11 million in research funding specifically for Vanderbilt Medical Center.

The players

Bo Watson

Bo Watson is a Tennessee State Senator who toured the facility to evaluate current care standards for patients.

Esther Helton-Haynes

Esther Helton-Haynes is a Tennessee State Representative who joined the visit to hear advocacy requests regarding patient services.

Erlanger Hospital

Erlanger Hospital operates the only clinic in the Chattanooga area dedicated to the treatment of ALS.

ALS Association

The ALS Association is an advocacy organization working to secure greater state assistance for clinical research and multidisciplinary patient care.

The details

The Erlanger Hospital facility remains the only specialized clinic in the Chattanooga area equipped to handle the complex needs of ALS patients. Advocates are requesting greater investment to facilitate local physical, occupational, and speech therapy programs alongside new research initiatives.

October 20, 2026: Legislators visited the Erlanger Hospital ALS Clinic.
2026: The Tennessee legislature approved $11 million for research at Vanderbilt.

Health Landscape

The push for local clinical trials marks a geographic extension of the research capacity initiated by the 2026 Tennessee legislative appropriation for Vanderbilt Medical Center research. This effort highlights the ongoing transition from centralized academic research to expanded community-based treatment access.

Expanded funding for multidisciplinary services would directly improve local access to essential physical, occupational, and speech therapies for residents living with ALS. Patients and their families currently rely on the Erlanger clinic as the singular regional resource for specialized disease management.

The takeaway

Advocates continue to emphasize that improving outcomes for those with ALS requires a robust support network beyond specialized hospital facilities. Ensuring state funding reaches regional clinics can significantly reduce the burden on patients seeking comprehensive long-term care.